[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 65, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 916157, "exercisedValue": 0, "unexercisedValue": 5736499}, {"maxAge": 1, "name": "Mr. Richard I. Eisenstadt M.B.A.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 619694, "exercisedValue": 0, "unexercisedValue": 273375}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 599255, "exercisedValue": 0, "unexercisedValue": 565469}, {"maxAge": 1, "name": "Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS", "age": 70, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 643040, "exercisedValue": 0, "unexercisedValue": 1459575}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "title": "Corporate Controller", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 4, "overallRisk": 5, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.86, "open": 9.714, "dayLow": 9.04, "dayHigh": 9.75, "regularMarketPreviousClose": 9.86, "regularMarketOpen": 9.714, "regularMarketDayLow": 9.04, "regularMarketDayHigh": 9.75, "exDividendDate": 1484870400, "beta": 0.069, "forwardPE": -5.404762, "volume": 4005909, "regularMarketVolume": 4005909, "averageVolume": 7061883, "averageVolume10days": 5002500, "averageDailyVolume10Day": 5002500, "bid": 9.9, "ask": 9.86, "bidSize": 900, "askSize": 800, "marketCap": 487858400, "fiftyTwoWeekLow": 2.09, "fiftyTwoWeekHigh": 14.84, "priceToSalesTrailing12Months": 1748.5964, "fiftyDayAverage": 10.3154, "twoHundredDayAverage": 5.37485, "currency": "USD", "enterpriseValue": 347867136, "floatShares": 47503307, "sharesOutstanding": 53728900, "sharesShort": 10813162, "sharesShortPriorMonth": 10011428, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.2013, "heldPercentInsiders": 0.010240001, "heldPercentInstitutions": 0.68255997, "shortRatio": 1.81, "shortPercentOfFloat": 0.2029, "impliedSharesOutstanding": 54600700, "bookValue": 2.845, "priceToBook": 3.191564, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -78466000, "trailingEps": -1.54, "forwardEps": -1.68, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 1246.836, "52WeekChange": 0.83434343, "SandP52WeekChange": 0.28643203, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ALT", "underlyingSymbol": "ALT", "shortName": "Altimmune, Inc.", "longName": "Altimmune, Inc.", "firstTradeDateEpochUtc": 1495805400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "dfbfc9cc-7a23-3560-b04c-b1a5faf1ec3e", "messageBoardId": "finmb_4866807", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.08, "targetHighPrice": 35.0, "targetLowPrice": 13.0, "targetMeanPrice": 21.75, "targetMedianPrice": 22.5, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 140779008, "totalCashPerShare": 2.62, "totalDebt": 788000, "quickRatio": 12.241, "currentRatio": 12.886, "totalRevenue": 279000, "debtToEquity": 0.524, "revenuePerShare": 0.005, "returnOnAssets": -0.27243, "returnOnEquity": -0.44153, "freeCashflow": -51968000, "operatingCashflow": -76583000, "revenueGrowth": 180.0, "operatingMargins": -62.26519, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-19"}]